Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$40.9 - $50.42 $2,535 - $3,126
-62 Reduced 77.5%
18 $1,000
Q2 2022

Aug 08, 2022

SELL
$42.98 - $49.77 $988 - $1,144
-23 Reduced 22.33%
80 $4,000
Q1 2022

May 10, 2022

SELL
$42.23 - $54.3 $84 - $108
-2 Reduced 1.9%
103 $5,000
Q4 2021

Feb 11, 2022

BUY
$50.62 - $56.47 $506 - $564
10 Added 10.53%
105 $6,000
Q2 2021

Aug 09, 2021

BUY
$46.28 - $52.75 $1,804 - $2,057
39 Added 69.64%
95 $5,000
Q3 2020

Nov 02, 2020

BUY
$42.51 - $52.42 $212 - $262
5 Added 9.8%
56 $3,000
Q2 2020

Aug 11, 2020

SELL
$39.49 - $44.36 $1,500 - $1,685
-38 Reduced 42.7%
51 $2,000
Q1 2020

May 15, 2020

BUY
$33.17 - $41.6 $364 - $457
11 Added 14.1%
89 $4,000
Q4 2019

Feb 13, 2020

BUY
$25.41 - $43.1 $406 - $689
16 Added 25.81%
78 $3,000
Q3 2019

Oct 17, 2019

BUY
$32.73 - $40.81 $2,029 - $2,530
62 New
62 $2,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.92B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.